Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results